CMS CAMERON MCKENNA NABARRO OLSWANG LLP
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Theatrical Producers (Except Motion Picture) and Miscellaneous Theatrical Services, Health and Allied Services, Not Elsewhere Classified, Legal Services, Individual and Family Social Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about CMS CAMERON MCKENNA NABARRO OLSWANG LLP
Live alerts from global media, monitored by Business Radar
2024-05-06 (beckershospitalreview.com)
Past Issues - Becker's Clinical Leadership
Archived Issues of Becker's Clinical Quality and Infection Control.
Read more
2024-05-06 (beckershospitalreview.com)
Past Issues - Becker's Clinical Leadership
Archived Issues of Becker's Clinical Quality and Infection Control.
Read more
2023-08-21 (nature.com)
Postacute sequelae of COVID-19 at 2 years | Medicine
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to postacute sequelae in multiple organ systems, but evidence is mostly limited to the first year postinfection. We built a cohort of 138,818 individuals with SARS-CoV-2 infection and 5,985,227 noninfected control group from the US Department of Veterans Affairs and followed them for 2 years to estimate the risks of death and 80 prespecified postacute sequelae of COVID-19 (PASC) according to care setting during the acute phase of infection. The increased risk of death was not significant beyond 6 months after infection among nonhospitalized but remained significantly elevated through the 2 years in hospitalized individuals. Within the 80 prespecified sequelae, 69% and 35% of them became not significant at 2 years after infection among nonhospitalized and hospitalized individuals, respectively. Cumulatively at2 years, PASC contributed 80.4( 95% confidence interval( CI): 71.6–89.6) and 642.8( 95% CI: 596.9–689.3) disability-adjusted
Read more
2023-05-02 (wionews.com)
World
The White House on Monday announced that the US will end its COVID-19 vaccination requirements for international travellers and federal workers on May 11, nearly three years after first enforcing the policy. `` Today, we are announcing that the administration will end the COVID-19 vaccine
Read more
2021-11-10 (beckershospitalreview.com)
Becker's Health IT & CIO Report
Becker's Health IT Report E-Weekly
Read more
2021-11-10 (beckershospitalreview.com)
Becker's Health IT & CIO Report
Becker's Health IT Report E-Weekly
Read more
2021-06-04 (pharmiweb.com)
What Is the Impact Of COVID-19 Crisis On Global Pharmaceutical Lipids Market?
According to a study by Future Market Insights (FMI), the global pharmaceutical lipids market is projected to grow at 10.7 % CAGR throughout the forecast period of 2021 to 2031.
Read more
2021-06-04 (pharmiweb.com)
What Is the Impact Of COVID-19 Crisis On Global Pharmaceutical Lipids Market?
According to a study by Future Market Insights (FMI), the global pharmaceutical lipids market is projected to grow at 10.7 % CAGR throughout the forecast period of 2021 to 2031.
Read more
2021-02-01 (khn.org)
Monday, February 1, 2021
Monday’s roundup covers masking, variants in the U.S., stimulus negotiations, vaccine choosiness, drug pricing and much more.
Read more
2021-02-01 (khn.org)
Monday, February 1, 2021
Monday’s roundup covers masking, variants in the U.S., stimulus negotiations, vaccine choosiness, drug pricing and much more.
Read more
2021-02-01 (khn.org)
Monday, February 1, 2021
Monday’s roundup covers masking, variants in the U.S., stimulus negotiations, vaccine choosiness, drug pricing and much more.
Read more
2021-02-01 (khn.org)
Monday, February 1, 2021
Monday’s roundup covers masking, variants in the U.S., stimulus negotiations, vaccine choosiness, drug pricing and much more.
Read more